Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Masimo (MASI) Capital Expenditures (2016 - 2026)

Masimo (MASI) has 16 years of Capital Expenditures data on record, last reported at $2.6 million in Q1 2025.

  • For Q1 2025, Capital Expenditures fell 57.38% year-over-year to $2.6 million; the TTM value through Mar 2025 reached $29.3 million, down 29.57%, while the annual FY2024 figure was $21.1 million, 52.05% down from the prior year.
  • Capital Expenditures reached $2.6 million in Q1 2025 per MASI's latest filing, down from $9.7 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $21.8 million in Q4 2022 and bottomed at -$34.5 million in Q1 2022.
  • Average Capital Expenditures over 5 years is $6.9 million, with a median of $9.7 million recorded in 2024.
  • Peak YoY movement for Capital Expenditures: soared 148.67% in 2022, then crashed 58.54% in 2023.
  • A 5-year view of Capital Expenditures shows it stood at -$6.3 million in 2021, then surged by 366.67% to $16.8 million in 2022, then tumbled by 35.12% to $10.9 million in 2023, then decreased by 11.01% to $9.7 million in 2024, then crashed by 73.2% to $2.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $2.6 million in Q1 2025, $9.7 million in Q2 2024, and $6.1 million in Q1 2024.